Search

Neuropathic Pain Market

Neuropathic Pain Market Size by drug class(Anticonvulsants drug, Tricyclic Antidepressants, Opioids, Capsaicin Cream, Steroids and Others), indication, distribution channel and regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2021 to 2028

Base Year: 2020 Historical Data: 2018-19
  • Report ID: TBI-12496
  • Published Date: Oct, 2021
  • Pages: 198
  • Category: Healthcare
  • Format: PDF
Buy @ $4699.00 Request Sample PDF

Global neuropathic pain market is expected to reach USD 10 billion by 2028, at a CAGR of 7.73% from 2021 to 2028. Global neuropathic pain market is witnessing a considerable growth owing to the surge in the number of cancer and diabetes cases and advancement in technology.

Market Overview:

This is the painful condition which usually comes under chronic pain. Neuropathic Pain happen happens due to progressive nerve disease and due to chronic disease. This may also happen some serious injury or infection. The chronic neuropathic pain can come up any time without showing any sign before. There is a possibility of even acute neuropathic pain, thou the chances are less. The non-neuropathic pain happens due to some injury or illness. The neuropathic pain does not happen because of some event or some activity or any kind of injury. People who are suffering from this condition may feel burning and shooting pain. In such condition, pain may be constant, or it may come and go at any time. There is no fixed time for it, and it does not come at a regular time interval. In such a condition, one can feel numbness or loss of sensation. The neuropathic pain could get worse with the time. The main causes for the neuropathic pain are chronic disease, infection, serious injuries and loss of limbs. Disease such as diabetes can make one feel like burning pain, numbness. According to one of the report, diabetes is responsible for 30% of neuropathic cases, because it impacts the working of nerves. The excessive consumption of alcohol for a long term can lead to chronic neuropathic disease. Same way serious accidents that affected the spine can lead to neuropathic pain. Infection can cause such pain rarely. For instance, Shingles can lead to neuropathic pain for some weeks. Due to limb loss, also people suffer from neuropathic pain. Such type of neuropathic pain is called phantom limb syndrome. The other reasons for the neuropathic pain include Vitamin B, thyroid problems, carpal tunnel syndrome, arthritis etc. 1 among  3 Americans suffers from chronic pain and in that 1 in 5 is suffering from the neuropathic pain. The increase in the population, the unhealthy lifestyle of the people, are the factors driving this market. The increasing number of geriatric population in the developed economies and the rise in awareness among people about Neuropathic pain in the developing economies are some more factors that are propelling this market. Also, the increase in the investment in R&D by big companies, the improvement in the drugs with the advancement in technologies and rising pain management centers are some more factors propelling the Nueropathic Pain market.

Get an overview of this study by requesting a free sample

Market Dynamics:

Drivers:
  • The increase in the number of cancer and diabetes cases

There are various chronic diseases that affect the nervous system such as, HIV, alcoholism, cancer, diabetes etc. The increase in the number of geriatric population across the globe are leading to an increasing number of the diabetic cases. Increasing cancer and diabetes cases leads to neuropathic pain, which ultimately drives the Neuropathic pain market.

  • Increasing pain management centers and the rising demand for generic drugs to alleviate pain levels

With the increasing number of Neuropathic pain cases, there is a demand for its cure. Some of the medications prescribed for neuropathic pain are anaesthetics, anticonvulsants and antidepressants. Common antidepressants include amitriptyline and nortriptyline whereas carbamazepine, valproic acid, felbamate, clonazepam and phenytoin are few of the most common anticonvulsants used for the treatment of neuropathic disorders. Many emergence of pain management centers are also going to drive the neuropathic pain market.

  • Advancement in technology and the increase in the number of ambulatory services

The advancement in technologies, procedures and the increasing number of ambulatory services specialized are helping the patient from neuropathic disorders. The people have become much more aware of the disease and about the treatment. These factors drive the Neuropathic pain market

Restraints:
  • The side effects due to opioids and steroids and the rapid rise in costs of branded drugs

The severe side effects of opioids and steroids such as increased heart rate, further chronic pain, nausea, vomiting, diarrhoea, chronic depression, headache and stroke, prevent the patients from using such prescriptions which include opioids and steroids, so these factors act as a restraint for the growth of this market and also the high cost of branded drugs also restraining neuropathic pain market.

Opportunities:
  • Various novel treatments such as Mirogabalinbesylate, a calcium channel blocker

The approval of treatments such as Mirogabalinbesylate, a calcium channel blocker has given a better solution for cure of neuropathic disorders. Furthermore, pharmaceutical companies are concentrating on the advancement of improved drugs to cater to the unmet demand of patients suffering from neuropathic pain, which supplements the market growth.

Challenges:
  • Lack of awareness towards the condition

Lack of awareness is the biggest challenge for the growth of this market. The people in some backwards regions are unaware about the neuropathic pain, the symptoms of it and about the treatment. The rising cost of treatment also obstruct the market growth, especially in underdeveloped regions.

Segmentation Analysis:

The global nueropathic pain market has been segmented based on drug class, indication, distribution channel and regions.

  • The drug class is divided into anticonvulsants, tricyclic antidepressants, opioids, capsaicin cream, steroids and others. Anticonvulsants drug is accounted to have the highest market share in 2020, reflecting a CAGR of over 8.3% during the forecast period. This is due to minimum risk of side effects by the drugs.
  • The indication segment includes Spinal Stenosis, Diabetic Neuropathy and Chemotherapy-induced Peripheral Neuropathy. Diabetic Neuropathy segment is accounted to have the largest market share of 48.07% in 2020. This is due to surging diabetic population.
  • The distribution channel segment includes hospitals, clinics, and research organizations. The hospital segment was accounted for the highest market value of USD 3.21 billion in 2020. This is due to the better infrastructure and facilities.
Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. North America is anticipated to held the highest share of the market in terms of value.

  • North America is accounted to have the highest market share in 2020. The market in the region will grow at CAGR of 9% in the forecast period. This is due to the advanced healthcare infrastructure in the region and also because of its strong distribution network.
  • The European market is expected to have the second-highest CAGR rate in the forecasting period. This is because the maximum number of the cancer patient in the region prefer chemotherapy which increases the requirement for neuropathic pain products.

North America Neuropathic Pain Market

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Competitive Analysis:

The key players are now concentrating on implementing strategies such as adopting new technology, product innovations, mergers & acquisitions, joint venture, alliances and partnerships to improve their market position in the global neuropathic pain industry.

In December 2017, Depomed Inc. announced the commercialization agreement with Collegium Pharmaceutical. This agreements helps, Collegium Pharmaceutical in commercializing the NUCYNTA pain franchise, and Depomed, Inc. will earn on royalty rate.

In January 2018, GSK Consumer Healthcare acquired Quell Wearable Pain Relief Technology of NeuropMetric Inc. organization for the sales in the global market except US. The acquisition expanded its product portfolio and is increasing the market share of the company.

List of key market players:

  • Eli Lilly and Company
  • AstellasPharma Inc.
  • Biogen Inc.
  • Baxter Healthcare Corporation
  • Pfizer, Inc.
  • Sanofi S.A
  • Abbott Laboratories
  • AstraZeneca
  • Johnson & Johnson Services Inc.
  • GlaxoSmithKline Plc

Key Target Audience

  • Healthcare Institute
  • Drug Manufacture
  • Pharmaceutical Companies
  • Government Authorities and R&D Institutions
  • World Health Organization
  • Consulting And Research Firm

Report Description:

  • Global neuropathic painMarket, Industry Analysis, Trends, Analysis and Forecast, 2021 to 2028 is a forthcoming/imminent research report which is to be published by The Brainy Insights.
  • 2020 is considered as the base year of the report. 2018 and 2019 are considered as the historic years and 2021 to 2028 are the forecast years. The global neuropathic painmarket is based on revenue (USD Million/Billion), volume and price. The report incorporates the market study on the basis of revenue, and volume. The study covers the market share revenue/market share/volume for each of the segments, regions and countries catering to global neuropathic painmarket. The regions analyzed for the market are Europe, Asia Pacific, North America, South America and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
  • The report encompasses with the relative data & information, which have been validated by the leading industry professionals and experts all across the globe. The research report also delivers an outline of the attractiveness of drug class, indication, distribution channel and regions which are deduced and formulated on the basis of their growth rate (CAGR), market size, and attractiveness by analyzing the present and future prospects to fathom market growth and development in future.
  • The report illustrates the detailed (both quantitative and qualitative) analysis of historical data, revenues, key developments, along with the crucial strategies adopted by key organizations catering to global neuropathic painmarket.  This offers vital and in depth insights in order to depict the overall market scenario.
  • The report offers the detailed study for the company profiles of key organizations operating in the global neuropathic painmarket and a comparative assessment based on their product offering, business overviews, geographic presence, business strategies, segment market share, product development & innovations, recent developments, joint venture, partnerships, mergers & acquisitions, strategic alliances, SWOT analysis, and key financial information. This helps in evaluating the overall competition present in the market scenario. 
  • The report provides an elaborative assessment of the porter’s five forces analysis coupled with SWOT analysis so as to provide business related data and information’s. Porter’s five forces model is analyzed to understand the overall competitive scenario that is prevailing in the market. Additionally, the SWOT analysis identifies both the positive and negative attributes of the market development which influences the company growth and development in order to sustain and survive in the long run.
  • Along with that, the report also focuses on the market related driving factors, growth limitations (restraints), potential industry opportunities, significant trends and development which acts as a key potential for the investors. 
  • Potential growth prospects along with the penetration rate analysis of the products (market related i.e., global neuropathic painmarket) is covered in order to comprehend the adoption rate and evaluate the market size. 

Frequesntly Asked Questions

The size of the nueropathic pain market was valued at USD 5.10 billion in 2020 and is anticipated to reach USD 10 billion by 2028.

Global nueropathic pain market is growing at a CAGR of 7.73% during the forecast period 2021-2028.

The global nueropathic pain market has been segmented based on drug class, indication, distribution channel and regions. The Anticonvulsants drug segment led the Nueropathic Pain market with a CAGR of 8.3% in forecasting period.

The North America region emerged as the largest market for the nueropathic pain.

The increasing number of cancer and diabetes cases and factors such as the emergence of pain management centers& demand for generic drugs to alleviate pain levels is the key driving factor for the nueropathic pain market.

Lack of awareness towards the condition may hamper the market growth.

The advent of various novel treatments such as Mirogabalinbesylate, a calcium channel blocker, and their approvalswill provide huge opportunities to the market.

Key players are Eli Lilly and Company, Astellas Pharma Inc., Biogen Inc., Baxter Healthcare Corporation, Pfizer, Inc., Sanofi S.A, Abbott Laboratories.

Get Your Report Customized

  • Further segmentation of the market on the basis of type, application, end use, product, technology, method, process and any other segment depending on the market
  • Segmentation on the basis of any specific country or region
  • Any segment can be classified on the basis of application
  • Application segment can be further divided on the basis of companies
  • The companies profiled are not limited, we can incorporate additional companies of your choice
  • We can split the company market share on the basis of product, application and region
  • Report can be prepared for any specific country/region/segment
  • Customers can be added on the basis of regions and countries
Request for Customization

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Drug Class
          4.3.2. Market Attractiveness Analysis By Indication
          4.3.3. Market Attractiveness Analysis By Distribution Channel
          4.3.4. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. The increasing number of cancer and diabetes cases
          5.2.2. Factors such as the emergence of pain management centers and demand for generic drugs to alleviate pain levels
          5.2.3. Technological advancement and the increasing number of ambulatory services
    5.3. Restrains
          5.3.1. Severe side effects of opioids and steroids and rapid rise in costs of branded drugs
    5.4. Opportunities
          5.4.1. The advent of various novel treatments such as Mirogabalin besylate, a calcium channel blocker, and their approvals
    5.5. Challenges
          5.5.1. Lack of awareness towards the condition

6. Global Neuropathic Pain Market Analysis and Forecast, By Drug Class
    6.1. Segment Overview
    6.2. Anticonvulsants drug
    6.3. Tricyclic Antidepressants
    6.4. Opioids
    6.5. Capsaicin Cream
    6.6. Steroids
    6.7. Others

7. Global Neuropathic Pain MarketAnalysis and Forecast, By Indication
    7.1. Segment Overview
    7.2. Diabetic Neuropathy
    7.3. Spinal Stenosis
    7.4. Chemotherapy-induced Peripheral Neuropathy

8. Global Neuropathic Pain MarketAnalysis and Forecast, By Distribution Channel
    8.1. Segment Overview
    8.2. Hospitals
    8.3. Clinics
    8.4. Research organizations

9. Global Neuropathic Pain MarketAnalysis and Forecast, By Regional Analysis
    9.1. Segment Overview
    9.2. North America
          9.2.1. U.S.
          9.2.2. Canada
          9.2.3. Mexico
    9.3. Europe
          9.3.1. Germany
          9.3.2. France
          9.3.3. U.K.
          9.3.4. Italy
          9.3.5. Spain
    9.4. Asia-Pacific
          9.4.1. Japan
          9.4.2. China
          9.4.3. India
    9.5. South America
          9.5.1. Brazil
    9.6. Middle East and Africa
          9.6.1. UAE
          9.6.2. South Africa

10. Global Neuropathic Pain Market-Competitive Landscape
    10.1. Overview
    10.2. Market Share of Key Players in the Neuropathic Pain Market
          10.2.1. Global Company Market Share
          10.2.2. North America Company Market Share
          10.2.3. Europe Company Market Share
          10.2.4. APAC Company Market Share
    10.3. Competitive Situations and Trends
          10.3.1. Product Launches and Developments
          10.3.2. Partnerships, Collaborations, and Agreements
          10.3.3. Mergers & Acquisitions
          10.3.4. Expansions

11. Company Profiles
    11.1. Eli Lily and Company
          11.1.1. Business Overview
          11.1.2. Company Snapshot
          11.1.3. Company Market Share Analysis
          11.1.4. Company Component Portfolio
          11.1.5. Recent Developments
          11.1.6. SWOT Analysis
    11.2. Astellas Pharma Inc.
          11.2.1. Business Overview
          11.2.2. Company Snapshot
          11.2.3. Company Market Share Analysis
          11.2.4. Company Component Portfolio
          11.2.5. Recent Developments
          11.2.6. SWOT Analysis
    11.3. Biogen Inc.
          11.3.1. Business Overview
          11.3.2. Company Snapshot
          11.3.3. Company Market Share Analysis
          11.3.4. Company Component Portfolio
          11.3.5. Recent Developments
          11.3.6. SWOT Analysis
    11.4. Baxter Healthcare Corporation
          11.4.1. Business Overview
          11.4.2. Company Snapshot
          11.4.3. Company Market Share Analysis
          11.4.4. Company Component Portfolio
          11.4.5. Recent Developments
          11.4.6. SWOT Analysis
    11.5. Pfizer Inc.
          11.5.1. Business Overview
          11.5.2. Company Snapshot
          11.5.3. Company Market Share Analysis
          11.5.4. Company Component Portfolio
          11.5.5. Recent Developments
          11.5.6. SWOT Analysis
    11.6. Sanofi S.A.
          11.6.1. Business Overview
          11.6.2. Company Snapshot
          11.6.3. Company Market Share Analysis
          11.6.4. Company Component Portfolio
          11.6.5. Recent Developments
          11.6.6. SWOT Analysis
    11.7. Abbott Laboratories
          11.7.1. Business Overview
          11.7.2. Company Snapshot
          11.7.3. Company Market Share Analysis
          11.7.4. Company Component Portfolio
          11.7.5. Recent Developments
          11.7.6. SWOT Analysis
    11.8. AstraZeneca
          11.8.1. Business Overview
          11.8.2. Company Snapshot
          11.8.3. Company Market Share Analysis
          11.8.4. Company Component Portfolio
          11.8.5. Recent Developments
          11.8.6. SWOT Analysis
    11.9. Johnson and Johnson Services Inc.
          11.9.1. Business Overview
          11.9.2. Company Snapshot
          11.9.3. Company Market Share Analysis
          11.9.4. Company Component Portfolio
          11.9.5. Recent Developments
          11.9.6. SWOT Analysis
    11.10. GlaxoSmithKline Plc.
          11.10.1. Business Overview
          11.10.2. Company Snapshot
          11.10.3. Company Market Share Analysis
          11.10.4. Company Component Portfolio
          11.10.5. Recent Developments
          11.10.6. SWOT Analysis
 

List of Table

1. Global Neuropathic Pain Market, By Drug Class, 2018-2028 (USD Billion)

2. Global Anticonvulsants Neuropathic Pain Market, By Region, 2018-2028 (USD Billion)

3. Global Tricyclic Antidepressants Neuropathic Pain Market, By Region, 2018-2028 (USD Billion)

4. Global Opioids Neuropathic Pain Market, By Region, 2018-2028 (USD Billion)

5. Global Capsaicin Cream Neuropathic Pain Market, By Region, 2018-2028 (USD Billion)

6. Global Steroids Neuropathic Pain Market, By Region, 2018-2028 (USD Billion)

7. Global Others Neuropathic Pain Market, By Region, 2018-2028 (USD Billion)

8. Global Neuropathic Pain Market, By Indication, 2018-2028 (USD Billion)

9. Global Diabetic Neuropathy Neuropathic Pain Market, By Region, 2018-2028 (USD Billion)

10. Global Spinal Stenosis Neuropathic Pain Market, By Region, 2018-2028 (USD Billion)

11. Global Chemotherapy-induced Peripheral Neuropathy Neuropathic Pain Market, By Region, 2018-2028 (USD Billion)

12. Global Neuropathic Pain Market, By Distribution Channel, 2018-2028 (USD Billion)

13. Global Hospitals Neuropathic Pain Market, By Region, 2018-2028 (USD Billion)

14. Global Clinics Neuropathic Pain Market, By Region, 2018-2028 (USD Billion)

15. Global Research organizations Neuropathic Pain Market, By Region, 2018-2028 (USD Billion)

16. Global Neuropathic Pain Market, By Region, 2018-2028 (USD Billion)

17. Global Neuropathic Pain Market, By North America, 2018-2028 (USD Billion)

18. North America Neuropathic Pain Market, By Drug Class, 2018-2028 (USD Billion)

19. North America Neuropathic Pain Market, By Indication, 2018-2028 (USD Billion)

20. North America Neuropathic Pain Market, By Distribution Channel, 2018-2028 (USD Billion)

21. U.S. Neuropathic Pain Market, By Drug Class, 2018-2028 (USD Billion)

22. U.S. Neuropathic Pain Market, By Indication, 2018-2028 (USD Billion)

23. U.S. Neuropathic Pain Market, By Distribution Channel, 2018-2028 (USD Billion)

24. Canada Neuropathic Pain Market, By Drug Class, 2018-2028 (USD Billion)

25. Canada Neuropathic Pain Market, By Indication, 2018-2028 (USD Billion)

26. Canada Neuropathic Pain Market, By Distribution Channel, 2018-2028 (USD Billion)

27. Mexico Neuropathic Pain Market, By Drug Class, 2018-2028 (USD Billion)

28. Mexico Neuropathic Pain Market, By Indication, 2018-2028 (USD Billion)

29. Mexico Neuropathic Pain Market, By Distribution Channel, 2018-2028 (USD Billion)

30. Europe Neuropathic Pain Market, By Drug Class, 2018-2028 (USD Billion)

31. Europe Neuropathic Pain Market, By Indication, 2018-2028 (USD Billion)

32. Europe Neuropathic Pain Market, By Distribution Channel, 2018-2028 (USD Billion)

33. Germany Neuropathic Pain Market, By Drug Class, 2018-2028 (USD Billion)

34. Germany Neuropathic Pain Market, By Indication, 2018-2028 (USD Billion)

35. Germany Neuropathic Pain Market, By Distribution Channel, 2018-2028 (USD Billion)

36. France Neuropathic Pain Market, By Drug Class, 2018-2028 (USD Billion)

37. France Neuropathic Pain Market, By Indication, 2018-2028 (USD Billion)

38. France Neuropathic Pain Market, By Distribution Channel, 2018-2028 (USD Billion)

39. U.K. Neuropathic Pain Market, By Drug Class, 2018-2028 (USD Billion)

40. U.K. Neuropathic Pain Market, By Indication, 2018-2028 (USD Billion)

41. U.K. Neuropathic Pain Market, By Distribution Channel, 2018-2028 (USD Billion)

42. Italy Neuropathic Pain Market, By Drug Class, 2018-2028 (USD Billion)

43. Italy Neuropathic Pain Market, By Indication, 2018-2028 (USD Billion)

44. Italy Neuropathic Pain Market, By Distribution Channel, 2018-2028 (USD Billion)

45. Spain Neuropathic Pain Market, By Drug Class, 2018-2028 (USD Billion)

46. Spain Neuropathic Pain Market, By Indication, 2018-2028 (USD Billion)

47. Spain Neuropathic Pain Market, By Distribution Channel, 2018-2028 (USD Billion)

48. Asia Pacific Neuropathic Pain Market, By Drug Class, 2018-2028 (USD Billion)

49. Asia Pacific Neuropathic Pain Market, By Indication, 2018-2028 (USD Billion)

50. Asia Pacific Neuropathic Pain Market, By Distribution Channel, 2018-2028 (USD Billion)

51. Japan Neuropathic Pain Market, By Drug Class, 2018-2028 (USD Billion)

52. Japan Neuropathic Pain Market, By Indication, 2018-2028 (USD Billion)

53. Japan Neuropathic Pain Market, By Distribution Channel, 2018-2028 (USD Billion)

54. China Neuropathic Pain Market, By Drug Class, 2018-2028 (USD Billion)

55. China Neuropathic Pain Market, By Indication, 2018-2028 (USD Billion)

56. China Neuropathic Pain Market, By Distribution Channel, 2018-2028 (USD Billion)

57. India Neuropathic Pain Market, By Drug Class, 2018-2028 (USD Billion)

58. India Neuropathic Pain Market, By Indication, 2018-2028 (USD Billion)

59. India Neuropathic Pain Market, By Distribution Channel, 2018-2028 (USD Billion)

60. South America Neuropathic Pain Market, By Drug Class, 2018-2028 (USD Billion)

61. South America Neuropathic Pain Market, By Indication, 2018-2028 (USD Billion)

62. South America Neuropathic Pain Market, By Distribution Channel, 2018-2028 (USD Billion)

63. Brazil Neuropathic Pain Market, By Drug Class, 2018-2028 (USD Billion)

64. Brazil Neuropathic Pain Market, By Indication, 2018-2028 (USD Billion)

65. Brazil Neuropathic Pain Market, By Distribution Channel, 2018-2028 (USD Billion)

66. Middle East and Africa Neuropathic Pain Market, By Drug Class, 2018-2028 (USD Billion)

67. Middle East and Africa Neuropathic Pain Market, By Indication, 2018-2028 (USD Billion)

68. Middle East and Africa Neuropathic Pain Market, By Distribution Channel, 2018-2028 (USD Billion)

69. UAE Neuropathic Pain Market, By Drug Class, 2018-2028 (USD Billion)

70. UAE Neuropathic Pain Market, By Indication, 2018-2028 (USD Billion)

71. UAE Neuropathic Pain Market, By Distribution Channel, 2018-2028 (USD Billion)

72. South Africa Neuropathic Pain Market, By Drug Class, 2018-2028 (USD Billion)

73. South Africa Neuropathic Pain Market, By Indication, 2018-2028 (USD Billion)

74. South Africa Neuropathic Pain Market, By Distribution Channel, 2018-2028 (USD Billion)

List of Figures 

1. Global Neuropathic Pain Market Segmentation

2. Neuropathic Pain Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Neuropathic Pain Market Attractiveness Analysis By Drug Class

9. Global Neuropathic Pain Market Attractiveness Analysis By Indication

10. Global Neuropathic Pain Market Attractiveness Analysis By Distribution Channel

11. Global Neuropathic Pain Market Attractiveness Analysis By Region

12. Global Neuropathic Pain Market: Dynamics

13. Global Neuropathic Pain Market Share by Drug Class (2021 & 2028)

14. Global Neuropathic Pain Market Share by Indication(2021 & 2028)

15. Global Neuropathic Pain Market Share by Distribution Channel(2021 & 2028)

16. Global Neuropathic Pain Market Share by Regions (2021 & 2028)

17. Global Neuropathic Pain Market Share by Company (2020)

This study forecasts revenue at global, regional, and country levels from 2018 to 2028. The segmentation of the global nueropathic pain market on the basis of below mentioned segments:

Global Neuropathic Pain Market by Drug Class:

  • Anticonvulsants
  • Tricyclic antidepressants
  • Opioids
  • Capsaicin cream
  • Steroids
  • Others

Global Neuropathic Pain Market by Indication:

  • Diabetic Neuropathy
  • Spinal Stenosis
  • Chemotherapy-induced Peripheral Neuropathy

Global Neuropathic Pain Market by Distribution Channel:

  • Hospitals
  • Clinics
  • Research organizations

Global Neuropathic Pain Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa         
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Ask for customization Request Sample Speak to analyst Inquire before buying

Flexible Purchase Options

  • Chapters of your choice
  • Quantitative Information for Historical & Forecasted Data
  • Regional/Country Level Reports
Request for Special Pricing

Get in touch with us

+1-315-215-1633

sales@thebrainyinsights.com

Our Clients

Why choose us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date